International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 74-78
Research Article
Gastric Cancer Profile in a Tertiary Care Centre: A Retrospective Study from Kashmir, India
 ,
 ,
 ,
 ,
Received
Feb. 2, 2026
Accepted
Feb. 26, 2026
Published
March 6, 2026
Abstract

Background Gastric cancer remains a major global health concern despite a declining incidence in several regions. It continues to contribute substantially to cancer-related morbidity and mortality worldwide.

Objective To analyze the demographic, clinical, and pathological profile of patients with gastric cancer presenting to a tertiary care centre in Kashmir, India.

Materials and Methods This retrospective observational study included all histopathologically confirmed cases of gastric carcinoma registered at the Hospital-Based Cancer Registry, Government Medical College, Anantnag, from January 2019 to December 2024. Data regarding age, sex, clinical presentation, anatomical site, histopathology, TNM stage, metastatic pattern, and treatment details were retrieved and analyzed using descriptive statistics.

Results A total of 175 patients were included, with a marked male predominance. Elderly patients constituted the majority of cases. The pyloric region was the most commonly involved anatomical site, followed by the gastric body and cardia. Histopathological evaluation revealed a predominance of adenocarcinoma. Most patients presented with locally advanced disease, with a substantial proportion having distant metastases at diagnosis. The liver was the most frequent site of metastatic involvement.

Conclusion Gastric cancer in Kashmir predominantly affects elderly males and commonly presents at an advanced stage, with pyloric involvement being most frequent. The high burden of advanced disease underscores the need for early detection strategies, including increased public awareness and timely endoscopic evaluation.

Keywords
INTRODUCTION

Gastric cancer remains a significant global health burden and continues to contribute substantially to cancer-related mortality. Worldwide, it accounts for over one million new cases and approximately eight hundred thousand deaths annually, ranking among the leading causes of cancer-related death.1 Although a gradual decline in incidence has been observed in several regions over recent decades, marked geographical variations persist. These differences are largely attributed to disparities in dietary patterns, lifestyle factors, prevalence of Helicobacter pylori infection, and socioeconomic conditions.

 

The incidence of gastric cancer shows a strong age-related increase, predominantly affecting older adults. Population-based data from the Surveillance, Epidemiology, and End Results (SEER) program indicate that gastric cancer is rare in younger individuals, with only a small proportion of cases occurring before the age of 35, while a substantial burden is observed in the elderly population.2 A consistent male predominance has been reported across populations, with men being affected two to three times more frequently than women3. This gender disparity has been linked to differences in environmental exposures, dietary habits, tobacco use, and hormonal influences.

 

Despite advances in diagnostic modalities and therapeutic strategies, gastric cancer continues to be diagnosed at an advanced stage in many developing countries. Early-stage disease is often asymptomatic or associated with nonspecific symptoms, leading to delays in clinical presentation and diagnosis. Furthermore, the absence of organized screening programs in high-risk regions contributes to late detection and poorer outcomes.4

 

India exhibits considerable regional variation in the incidence and presentation of gastric cancer, reflecting diverse cultural, dietary, and environmental influences. However, data from certain regions, including the Kashmir valley, remain limited. The present study aims to analyze the demographic characteristics and clinicopathological profile of gastric cancer patients presenting to a tertiary care centre in Kashmir, thereby contributing region-specific evidence to better understand disease patterns and inform strategies for early detection and improved management.

 

MATERIALS AND METHODS

This retrospective observational study was conducted in the Department of Radiation Oncology, Government Medical College, Anantnag, Kashmir, between January 2024 and December 2024.

 

Inclusion Criteria:

All histopathologically confirmed cases of gastric carcinoma across all age groups and both sexes were included.


Exclusion Criteria:

Patients diagnosed with non-malignant gastric lesions, lymphomas, or non-epithelial gastric tumors were excluded.


Data Collection and Analysis: Demographic data, clinical features, anatomical location, histopathology, and TNM stage were obtained from institutional records available in the Hospital-Based Cancer Registry. Diagnosis was established using upper gastrointestinal endoscopy, contrast-enhanced CT (CECT), and histopathological confirmation. Staging followed the TNM classification. Descriptive statistics were used for analysis, and categorical data were expressed as percentages.

 

RESULTS

A total of 175 patients were included in the study. Majority of the patients belonged to the age group of 45 to 65 years (Fig. 1) Constitutional and gastrointestinal symptoms were the predominant modes of presentation, with weight loss and anorexia being the most frequently reported complaints, indicating a high burden of systemic involvement at diagnosis. Upper gastrointestinal bleeding manifestations and epigastric discomfort were also commonly observed, while recurrent vomiting was comparatively less frequent, suggesting variable degrees of gastric outlet or luminal compromise (Table 1).

 

Histopathological evaluation revealed a striking predominance of malignant epithelial tumors, with adenocarcinoma accounting for nearly all cases. Non-epithelial malignancies were distinctly uncommon, underscoring the overwhelming burden of adenocarcinoma in gastric malignancies within the study population (Table 2).

 

Disease staging at presentation demonstrated that the majority of patients were diagnosed at advanced stages. While a small proportion of cases were identified at an early stage, most patients belonged to stage II and stage III categories, reflecting delayed clinical presentation and diagnosis. A substantial subset of patients had metastatic disease at the time of diagnosis, emphasizing the aggressive nature of the disease and the challenges in early detection (Table 3).

 

Among patients with metastatic disease, the liver emerged as the most frequent site of distant spread, highlighting its vulnerability in advanced gastric malignancy. Pulmonary and skeletal metastases were less commonly encountered, while a small proportion of patients exhibited either multiple metastatic sites or involvement of less common organs (Table 4).

 

Overall, the results demonstrate a clinical profile characterized by late-stage presentation, predominance of adenocarcinoma, and a high frequency of distant metastasis, particularly involving the liver.

 

Table 1: Presenting symptoms in the study population

Symptom

Frequency (n)

Percentage (%)

Weight loss

58

33

Anorexia

47

27

Melena

30

17

Epigastric pain

26

15

Recurrent vomiting

14

8

Total

175

100

 

Table 2: Histopathological types

Histopathological Type

Number of Cases

Percentage

Adenocarcinoma

172

98%

Gastrointestinal stromal tumor (GIST)

3

2%

Total

175

100%

 

Table 3: TNM Stage Distribution (n = 175)

TNM Stage

Number of Cases

Percentage

Stage I

12

7%

Stage II

68

39%

Stage III

52

30%

Stage IVA

6

3.40%

Stage IVB

37

21%

Total

175

100%

 

Table 4: Site of Metastasis

Site of Metastasis

Number of Cases

Percentage

Liver

29

68%

Lungs

8

19%

Bones

3

7%

Others / Multiple sites

3

6%

Total

43

100%

 

Fig. 1: Age distribution in the present study

 

DISCUSSION

Gastric cancer continues to pose a significant oncological challenge worldwide, particularly in developing regions where delayed presentation remains common. The present study provides a comprehensive overview of the demographic and clinicopathological profile of gastric cancer patients managed at a tertiary care centre in Kashmir, India, and highlights several important trends consistent with existing literature.5

 

A clear male predominance was observed in the study population, which aligns with global epidemiological data reporting a two- to three-fold higher incidence of gastric cancer among males. This gender disparity has been attributed to differences in lifestyle factors, dietary habits, tobacco use, and hormonal influences. The majority of patients were older adults, reflecting the well-established association between increasing age and gastric cancer risk. Similar age distributions have been reported in large population-based studies, reinforcing the role of cumulative environmental exposure and age-related genetic alterations in gastric carcinogenesis.6,7

 

Anatomically, the pyloric region was the most commonly involved site in this cohort. This finding contrasts with trends from Western countries, where a rising incidence of proximal and gastroesophageal junction cancers has been noted. The predominance of distal gastric cancers in the present study may reflect regional dietary patterns, high prevalence of Helicobacter pylori infection, and socioeconomic factors prevalent in the Kashmir valley. Such regional variation underscores the importance of local epidemiological data in guiding screening and prevention strategies.5

 

Histopathological analysis demonstrated an overwhelming predominance of adenocarcinoma, which is consistent with global patterns of gastric malignancy. The rarity of non-epithelial tumors such as gastrointestinal stromal tumors in this cohort further emphasizes the central role of adenocarcinoma in gastric cancer burden and supports the continued focus on this entity in clinical and research settings.8,9

 

A notable finding of this study was the advanced stage at diagnosis in the majority of patients. Most cases were classified as stage II or III, with a considerable proportion presenting with metastatic disease. This late presentation mirrors observations from other Indian and South Asian studies and likely reflects nonspecific early symptoms, lack of awareness, and limited access to early diagnostic endoscopy.10 The liver emerged as the most common site of distant metastasis, consistent with the hematogenous spread pattern of gastric cancer reported in previous studies.11

 

The predominance of advanced-stage disease at presentation highlights the urgent need for early detection strategies. Public education regarding alarm symptoms, improved access to diagnostic endoscopy, and targeted screening of high-risk populations could potentially facilitate earlier diagnosis and improve outcomes. While this study is limited by its retrospective nature and single-centre design, it offers valuable insight into the regional pattern of gastric cancer and provides a foundation for future multicentric and population-based research in Kashmir.

 

Limitations

This was a single-centre, retrospective study with limited regional representation. Some patients may have been referred elsewhere, and detailed follow-up data were unavailable. However, as one of the major oncology centres in the region, this study offers a representative snapshot of gastric cancer patterns in Kashmir.

 

CONCLUSION

Gastric cancer in Kashmir predominantly affects elderly males and commonly involves the pyloric region. Most patients present at advanced stages, highlighting the urgent need for awareness programs and early endoscopic screening. Population-based registries and multicentric studies are essential for defining regional risk factors and improving early detection.

 

REFERENCES

  1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015. JAMA Oncol. 2017 Apr 1;3(4):524.
  2. Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. JNCI: Journal of the National Cancer Institute. 2015 Jun;107(6).
  3. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893–917.
  4. Ramachandran R, Grantham T, Parvataneni S, Budh D, Gollapalli S, Reddy M, et al. Gastric Cancer: Clinical Features, Screening, Diagnosis, Treatment, and Prevention. J Community Hosp Intern Med Perspect. 2024 Mar 1;14(2).
  5. Barad AK, Mandal SK, Harsha HS, Sharma BM, Singh TS. Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India. J Gastrointest Oncol. 2014 Apr;5(2):142–7.
  6. Wang S, Zheng R, Arnold M, Abnet C, Zeng H, Zhang S, et al. Global and national trends in the age‐specific sex ratio of esophageal cancer and gastric cancer by subtype. Int J Cancer. 2022 Nov 22;151(9):1447–61.
  7. Dore MP, Manca A, Alfonso Pensamiento MC, Delitala AP, Fanciulli G, Piana AF, et al. Male Predominance of Gastric Cancer among Patients with Hypothyroidism from a Defined Geographic Area. J Clin Med. 2020 Jan 3;9(1).
  8. Anderson WF. Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults. JAMA. 2010 May 5;303(17):1723.
  9. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D’Amico TA, Das P, et al. Gastric Cancer. Journal of the National Comprehensive Cancer Network. 2010 Apr;8(4):378–409.
  10. Mabogunje OA, Subbuswamy SG, Lawrie JH. The two histological types of gastric carcinoma in Northern Nigeria. Gut. 1978 May;19(5):425–9.
  11. Luo Z, Rong Z, Huang C. Surgery Strategies for Gastric Cancer With Liver Metastasis. Front Oncol. 2019 Dec 6;9.  
Recommended Articles
Research Article Open Access
Assessment Of Knowledge, Attitude and Practice on Chronopharmacology Among the Clinical Doctors in A Tertiary Care Hospital – A Cross-Sectional Study
2026, Volume-7, Issue 2 : 650-656
Research Article Open Access
A Study of Clinical Profile and Outcome of Bronchiolitis in Children of Age 1–24 Months at A Tertiary Care Hospital in South India
2026, Volume-7, Issue 2 : 557-564
Case Report Open Access
Bullet, Blood and Airway – Gun Shot Wound Face Managed with Limited Resources
2026, Volume-7, Issue 2 : 592-596
Original Article Open Access
Morphological and Anatomical Variations of the Coronary Arteries: A Cadaveric Study
2026, Volume-7, Issue 1 : 3161-3166
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
14 Views
21 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved